IN201741031902A - - Google Patents
Info
- Publication number
- IN201741031902A IN201741031902A IN201741031902A IN201741031902A IN201741031902A IN 201741031902 A IN201741031902 A IN 201741031902A IN 201741031902 A IN201741031902 A IN 201741031902A IN 201741031902 A IN201741031902 A IN 201741031902A IN 201741031902 A IN201741031902 A IN 201741031902A
- Authority
- IN
- India
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201741031902A IN201741031902A (fr) | 2017-09-08 | 2017-09-08 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201741031902A IN201741031902A (fr) | 2017-09-08 | 2017-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN201741031902A true IN201741031902A (fr) | 2019-03-15 |
Family
ID=86850777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN201741031902A IN201741031902A (fr) | 2017-09-08 | 2017-09-08 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN201741031902A (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112480086A (zh) * | 2020-12-23 | 2021-03-12 | 中山奕安泰医药科技有限公司 | 奥斯替尼的精制方法 |
| CN115819406A (zh) * | 2023-02-24 | 2023-03-21 | 淄博百极荣创医药科技有限公司 | 3-(4-嘧啶)-1h-吲哚类化合物的合成方法 |
| WO2023194531A1 (fr) * | 2022-04-07 | 2023-10-12 | Astrazeneca Ab | Procédé amélioré de production d'osimertinib |
-
2017
- 2017-09-08 IN IN201741031902A patent/IN201741031902A/en unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112480086A (zh) * | 2020-12-23 | 2021-03-12 | 中山奕安泰医药科技有限公司 | 奥斯替尼的精制方法 |
| WO2023194531A1 (fr) * | 2022-04-07 | 2023-10-12 | Astrazeneca Ab | Procédé amélioré de production d'osimertinib |
| CN115819406A (zh) * | 2023-02-24 | 2023-03-21 | 淄博百极荣创医药科技有限公司 | 3-(4-嘧啶)-1h-吲哚类化合物的合成方法 |